01 1Viatris
01 1RALTEGRAVIR POTASSIUM USP (PROCESS-II)
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2016-09-02
Pay. Date : 2016-06-21
DMF Number : 30595
Submission : 2016-06-24
Status : Active
Type : II
20
Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is RALTEGRAVIR POTASSIUM USP (PROCESS-II), with a corresponding US DMF Number 30595.
Remarkably, this DMF maintains an Active status since its submission on June 24, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 02, 2016, and payment made on June 21, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
